Liver-Directed Therapies in Patients With Advanced Neuroendocrine Tumors

06/04/2012 - 06/04/2013

Natalie B. Jones, MD; Manisha H. Shah, MD; Mark Bloomston, MD
CME Released: 06/04/2012; Valid for credit through 06/04/2013, From JNCCN Journal of the National Comprehensive Cancer Network

This activity is intended for primary care physicians, oncologists, gastroenterologists, surgeons, and other physicians who care for patients with NETs. The goal of this activity is to evaluate treatment strategies for liver metastases of NETs. Upon completion of this activity, participants will be able to:

  1. Distinguish the most important prognostic factor for survival in cases of NETs
  2. Analyze surgical options for the treatment of liver metastases associated with NETs
  3. Assess the use of embolization of liver metastases associated with NETs
  4. Evaluate other treatment modalities of liver metastases associated with NETs

Click here for more information.


Print Friendly, PDF & Email